Select your timezone:

State-of-the-Art Session
Hematopoietic stem cells transplantation, classical and new indications

Wednesday September 14, 2022 | 16:00 to 17:30
Room: C3
Track: Bone Marrow

Video is available - Log in to view. You must be registered to the event to view content


For attending this session, you can claim 1.5 EACCME credits

Learning Objectives

After this session, the attendees should be able:
- To know the state of the art about autologous hematopoietic stem cell transplantation in autoimmune diseases, indications, preparative regimens, and complications
- To increase knowledge about donor selection, use of different preparative regimens, and relapse prevention strategies in patients with acute leukemia
- To understand the mechanisms by which an allogeneic hematopoietic stem cell transplant can prevent the rejection of a solid organ transplant
- To know the available strategies for the prevention and treatment of PTLD


Prof. Maria Carolina O Rodrigues, Brazil
Autologous HSCT in autoimmune diseases (EG: multiple sclerosis)

Damiano Rondelli, United States
Allogeneic HSCT in ALL/AML. The best donor, conditioning, prevention of relapse

Prof. Ephraim J Fuchs, United States
Allo HSCT as inducing immune tolerance to solid organs transplantation

Ibrahim Yakoub-Agha, France
CAR T cells therapy

© 2024 TTS 2022